Besides myeloid and lymphatic tumors bearing eosinophilia and PDGFRB rearrangement, PDGFRB rearrangement also could occur in a portion of Ph-like ALL patients.[10] NGS technology could identify the types of fusion gene and provides a reliable basis for disease diagnosis and accurate treatment. This evidence concerns the gene PDGFRB and Increased total eosinophil count.